Specifically, in this work we have characterized the transcriptome and proteome of liver and colon cancer cells after treatment with HME, providing several examples of deregulated p53 target genes, which can explain part of our observed phenotypes. This evidence concerns the gene TP53 and malignant colon neoplasm.